Belzutifan plus cabozantinib maintained durable antitumor activity in advanced clear cell renal cell carcinoma, per phase 3 ...

Investigators from Shanghai, China, report responses above 90% by using levantinib and tislelizumab to treat patients with a ...

Adding cabozantinib to first-line treatment with nivolumab and ipilimumab improved PFS — but not OS — in patients with RCC.

Russian mRNA cancer 'vaccine' shows promise in pre-clinical trials, part of growing immunotherapy trend in cancer treatment.

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Approximately 80 percent of patients with bladder cancer showed a reduction in tumor size, with no reported side effects ...

A brilliant first half enabled the Emirates Lions to reignite their quest for a top eight or even top four spot on the ...

Welcome to the AVITA Medical fourth-quarter 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference ...

Warriors: Abyss has deceptively deep action hooks, but they go to waste in a shallow Hades riff that doesn't take much skill ...

Shares of BioNTech SE (NASDAQ:BNTX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seventeen research firms that are currently covering the firm, Marketbeat ...

Equities researchers at Zacks Small Cap lowered their Q2 2025 earnings per share (EPS) estimates for shares of Arrowhead Pharmaceuticals in a report issued on Wednesday, February 12th. Zacks Small Cap ...